Clinical Trials in Tennessee

Showing 10861-10880 of 15,329 trials

Open-Label Study to Assess the Safety/Tolerability in Patients With Solid Tumors

NCT00820560

To establish the maximum tolerated dose (MTD) of INCB007839 given as multiple doses for 28 days and to determine if a higher MTD can be established when INCB007839 is administered in combination with prophylactic anticoagulation and with a 2 and a half day (5 doses) treatment interruption every two weeks.

Solid Tumors and Hematologic Malignancy

Incyte Corporation41 participantsStarted Jan 2005

Aurora, Colorado, United States • Baltimore, Maryland, United States • Philadelphia, Pennsylvania, United States +1 more locations

COMPLETEDPhase 229 miles

YM443 in Subjects With Functional Dyspepsia

NCT00102310

The primary objective of this study will be to characterize the dose response profile of YM443 in subjects with functional dyspepsia (FD) to enable the selection of doses for the Phase 3 clinical trial.

IndigestionNausea

Astellas Pharma Inc416 participantsStarted Mar 2004

Huntsville, Alabama, United States • Little Rock, Arkansas, United States • Anaheim, California, United States +56 more locations

Open-Label Study to Assess the Safety/Tolerability in Patients With Solid Tumors

YM443 in Subjects With Functional Dyspepsia

Find Trials by Condition in Tennessee

OSI-774 (Tarceva) Plus Gemcitabine in Patients With Locally Advanced, Unresectable or Metastatic Pancreatic Cancer.

The Safety, Tolerability And Metabolism Of GSK221149A, In Pregnant Women (30-36 Weeks), In Pre-Term Labor

Dolutegravir Compared to Darunavir/Ritonavir , Each in Combination With Dual Nucleoside Reverse Transcriptase Inhibitors (NRTIs) in ART-naive Subjects

EGEN-001 in Treating Patients With Persistent or Recurrent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer

Treatment Algorithm to Reduce the Use of Vancomycin in Adults With Blood Stream Infection

Trial of IMO-3100 in Patients With Moderate to Severe Plaque Psoriasis

A Study of the Trabecular Micro-bypass Stent in Combination With Cataract Surgery in Subjects With Open Angle Glaucoma

Study to Evaluate the Efficacy and Safety of P-3058 Nail Solution in the Treatment of Onychomycosis

Phase II Study of the Safety and Efficacy of the Relay Thoracic Stent-Graft

Alendronate to Prevent Loss of Bronchoprotection in Asthma

Gemcitabine and Docetaxel in Combination With Pazopanib (Gem/Doce/Pzb) for the Neoadjuvant Treatment of Soft Tissue Sarcoma (STS)

Study to Assess the Safety and Tolerability of Intravenous Carbamazepine in Adults With Epilepsy

Pemetrexed and Cisplatin in Treating Patients With Advanced, Persistent, or Recurrent Cervical Cancer

3-year Follow-up Study to Assess the Viral Activity in Hepatitis C Patients Who Failed Feeder DEB025/Alisporivir Study

Rituximab, Cladribine, and Temsirolimus in Treating Patients With Newly Diagnosed Mantle Cell Lymphoma

A Dose Ranging Trial of GSK1349572 and 2 NRTI in HIV-1 Infected, Therapy Naive Subjects

Smartphone Ophthalmoscope of Lens Vascularity to Estimate Gestational Age

An Observational Cohort Study of the Safety and Efficacy of Fibrinogen Concentrate, Human (FCH) in Subjects With Congenital Fibrinogen Deficiency